Table 2.
Demographics, baseline characteristics, and clinical outcomes of patients with confirmed COVID-19.
| Clinical presentation* | Confidence interval 95% | Heterogeneity test, I2 (%)** | Heterogeneity test, P Value** | Number of Studies | |
|---|---|---|---|---|---|
| Age, years | 48 (mean) | 43–50 | 98 | <0.001 | 23 |
| Sex (Male) | 55 (%) | 50–57.5 | 88.4 | <0.001 | 24 |
| Fever | 87 (%) | 73–93 | 98 | <0.001 | 18 |
| Cough | 68 (%) | 55.5–74 | 86 | <0.001 | 18 |
| Fatigue | 39 (%) | 29–52.5 | 93 | <0.001 | 14 |
| Sputum production/Expectoration | 31 (%) | 19–39 | 92 | <0.001 | 9 |
| Myalgia | 24 (%) | 14–43 | 92 | <0.001 | 9 |
| Dyspnea | 24 (%) | 12.6–32 | 92 | <0.001 | 11 |
| Sore throat | 14 (%) | 7.8–17 | 52 | 0.06 | 9 |
| Headache | 14 (%) | 8.3–18 | 77 | <0.001 | 16 |
| Diarrhea | 8 (%) | 4.6–11.4 | 70 | <0.001 | 18 |
| Rhinorrhea | 7 (%) | 3–12 | 0 | 0.43 | 6 |
| Nausea and vomiting | 6.5 (%) | 2.7–13 | 84 | <0.001 | 6 |
| Outcome | |||||
| Hospitalized | 81 (%) | 68–94 | 95 | <0.001 | 7 |
| Critical condition/ICU | 25.6 (%) | 6.7–48 | 99 | <0.001 | 8 |
| CFR (all age group) | 6 (%) | 4–8.5 | 89.6 | <0.001 | 49 |
*Age is an exception, presented in mean age in years. ** Greater than 50% is considered high heterogeneity, less than 50% is considered low heterogeneity. A low p value (<0.05) is consistent with high heterogeneity. Case fatality rate (CFR).